Literature DB >> 16086162

Viral evasion of the MHC class I antigen-processing machinery.

Sandra Loch1, Robert Tampé.   

Abstract

In their adaptation to the immune system in vertebrates, viruses have been forced to evolve elaborate strategies for evading the host's immune response. To ensure life-long persistence in the host, herpes viruses, adenoviruses and retroviruses have exploited multiple cellular pathways for their purpose, including the class I antigen-processing machinery. Attractive and prominent targets for viral attacks are the proteasome complex, the transporter associated with antigen processing, and MHC class I molecules. This review briefly outlines the different mechanisms of viral interference with the antigen-presentation pathway.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16086162     DOI: 10.1007/s00424-005-1420-8

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  97 in total

1.  Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins.

Authors:  S Ishido; C Wang; B S Lee; G B Cohen; J U Jung
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  Cutting edge: adenovirus E19 has two mechanisms for affecting class I MHC expression.

Authors:  E M Bennett; J R Bennink; J W Yewdell; F M Brodsky
Journal:  J Immunol       Date:  1999-05-01       Impact factor: 5.422

Review 3.  Specificity of the proteasome and the TAP transporter.

Authors:  S Uebel; R Tampé
Journal:  Curr Opin Immunol       Date:  1999-04       Impact factor: 7.486

Review 4.  Viral strategies of immune evasion.

Authors:  H L Ploegh
Journal:  Science       Date:  1998-04-10       Impact factor: 47.728

5.  Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction.

Authors:  E J Wiertz; D Tortorella; M Bogyo; J Yu; W Mothes; T R Jones; T A Rapoport; H L Ploegh
Journal:  Nature       Date:  1996-12-05       Impact factor: 49.962

6.  A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter.

Authors:  H Hengel; J O Koopmann; T Flohr; W Muranyi; E Goulmy; G J Hämmerling; U H Koszinowski; F Momburg
Journal:  Immunity       Date:  1997-05       Impact factor: 31.745

7.  Differential association between two human MHC class I antigens and an adenoviral glycoprotein.

Authors:  L Severinsson; I Martens; P A Peterson
Journal:  J Immunol       Date:  1986-08-01       Impact factor: 5.422

8.  An adenovirus glycoprotein binds heavy chains of class I transplantation antigens from man and mouse.

Authors:  C Signäs; M G Katze; H Persson; L Philipson
Journal:  Nature       Date:  1982-09-09       Impact factor: 49.962

9.  Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47.

Authors:  K Ahn; T H Meyer; S Uebel; P Sempé; H Djaballah; Y Yang; P A Peterson; K Früh; R Tampé
Journal:  EMBO J       Date:  1996-07-01       Impact factor: 11.598

10.  Herpes simplex virus type 2 ICP47 inhibits human TAP but not mouse TAP.

Authors:  R Tomazin; N E van Schoot; K Goldsmith; P Jugovic; P Sempé; K Früh; D C Johnson
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

View more
  11 in total

Review 1.  Bats: important reservoir hosts of emerging viruses.

Authors:  Charles H Calisher; James E Childs; Hume E Field; Kathryn V Holmes; Tony Schountz
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

2.  Exosome-driven antigen transfer for MHC class II presentation facilitated by the receptor binding activity of influenza hemagglutinin.

Authors:  James S Testa; Geraud S Apcher; Joseph D Comber; Laurence C Eisenlohr
Journal:  J Immunol       Date:  2010-11-03       Impact factor: 5.422

Review 3.  Viral proteins interfering with antigen presentation target the major histocompatibility complex class I peptide-loading complex.

Authors:  Gustav Røder; Linda Geironson; Iain Bressendorff; Kajsa Paulsson
Journal:  J Virol       Date:  2008-04-30       Impact factor: 5.103

Review 4.  Alternative pathways for MHC class I presentation: a new function for autophagy.

Authors:  Magali Chemali; Kerstin Radtke; Michel Desjardins; Luc English
Journal:  Cell Mol Life Sci       Date:  2011-03-10       Impact factor: 9.261

Review 5.  Intracellular peptide transporters in human--compartmentalization of the "peptidome".

Authors:  Meike Herget; Robert Tampé
Journal:  Pflugers Arch       Date:  2006-05-18       Impact factor: 3.657

Review 6.  Targeted degradation of ABC transporters in health and disease.

Authors:  Daphne Nikles; Robert Tampé
Journal:  J Bioenerg Biomembr       Date:  2007-12       Impact factor: 2.945

7.  Effect of human leukocyte antigen homozygosity on rubella vaccine-induced humoral and cell-mediated immune responses.

Authors:  Richard B Kennedy; Inna G Ovsyannikova; Robert A Vierkant; Robert M Jacobson; Gregory A Poland
Journal:  Hum Immunol       Date:  2009-11-05       Impact factor: 2.850

Review 8.  The intracellular antigen transport machinery TAP in adaptive immunity and virus escape mechanisms.

Authors:  Christian Schölz; Robert Tampé
Journal:  J Bioenerg Biomembr       Date:  2005-12       Impact factor: 3.853

9.  The ly49 gene family. A brief guide to the nomenclature, genetics, and role in intracellular infection.

Authors:  Alan Rowe Schenkel; Luke C Kingry; Richard A Slayden
Journal:  Front Immunol       Date:  2013-04-16       Impact factor: 7.561

10.  The E5 protein of the human papillomavirus type 16 down-regulates HLA-I surface expression in calnexin-expressing but not in calnexin-deficient cells.

Authors:  Myriam Gruener; Ignacio G Bravo; Frank Momburg; Angel Alonso; Pascal Tomakidi
Journal:  Virol J       Date:  2007-10-30       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.